CD molecules (ligands)

OP-5244 is a potent and orally active inhibitor of CD73 , with an IC 50 of 0.25 nM. OP-5244 reverses immunosuppression through blocking of adenosine production, and has the potential for the cancer researchIn VitroOP-5244 inhibits the production of

OP-5244 sodium is a potent and orally active inhibitor of CD73 , with an IC 50 of 0.25 nM. OP-5244 sodium reverses immunosuppression through blocking of adenosine production, and has the potential for the cancer research.Appearance:SolidIC50&amp

OP-5244 sodium is a potent and orally active inhibitor of CD73 , with an IC 50 of 0.25 nM. OP-5244 sodium reverses immunosuppression through blocking of adenosine production, and has the potential for the cancer research.Appearance:SolidIC50&amp

OP-5244 sodium is a potent and orally active inhibitor of CD73 , with an IC 50 of 0.25 nM. OP-5244 sodium reverses immunosuppression through blocking of adenosine production, and has the potential for the cancer research.Appearance:SolidIC50&amp

OX-40 ligand

OX-40 ligand

Pavurutamab (AMG-701) is a bispecific T cell engager molecule that anti- CD3 and anti- B cell maturation antigens ( BCMA ). Pavurutamab has an extended half-life based on Pacanalotamab ( HY-P99798 ). The Fc of Pavurutamab is coupled to molecules to

PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase ( CD73 ) inhibitor with K i s of 9.03 nM (rat) and 2.21 nM (human)In VitroMetabolism : Only a small percentage (&lt23%) of PSB-12379 (10g) is metabolized under the applied

PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase ( CD73 ) inhibitor with K i s of 9.03 nM (rat) and 2.21 nM (human)In VitroMetabolism : Only a small percentage (&lt23%) of PSB-12379 (10g) is metabolized under the applied

PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase ( CD73 ) inhibitor with K i s of 9.03 nM (rat) and 2.21 nM (human)In VitroMetabolism : Only a small percentage (&lt23%) of PSB-12379 (10g) is metabolized under the applied

PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase ( CD73 ) inhibitor with K i s of 9.03 nM (rat) and 2.21 nM (human)In VitroMetabolism : Only a small percentage (&lt23%) of PSB-12379 (10g) is metabolized under the applied

RANK ligand